Patent AnalyticsExaminers
Menu

Application

14813658 · 1-(5-TERT-BUTYL-2-PHENYL-2H-PYRAZOL-3-YL)-3-[2-FLUORO-4-(1-METHYL-2-OXO-2,3-DIHYDRO-1H-IMIDAZO[4,5-B]PYRIDIN-7-YLOXY)-PHENYL]-UREA AND RELATED COMPOUNDS AND THEIR USE IN THERAPY

Filed 2015-07-30 · Granted · Patent 9439893 (2016-09-13) The official file ↗The patent and its PDF ↗ · Art unit 1625 · Examiner Niloofar Rahmani Easy · CPC A61K 31/437 · INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL (THE) · Clark+Elbing LLP

Office actions
0
first was Notice of allowance
RCEs
0
no appeal
To first action
9.2 mo
to disposition 13.5 mo
Statutes raised
·
0 actions read
Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in